Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abnoba India is the Indian subsidiary of Abnoba GmbH, a German pharmaceutical company specializing in mistletoe therapy for cancer treatment. The company's flagship product, AbnobaVISCUM, is a mistletoe (Viscum album) extract used in integrative oncology to improve the quality of life and immune function of cancer patients. Abnoba India manages the distribution, regulatory compliance, and clinical education for these therapies across the Indian market. Their approach combines traditional herbal medicine with modern pharmaceutical manufacturing standards, focusing on supportive care for various solid tumors and hematological malignancies. The company provides specialized training to healthcare professionals on the administration and benefits of mistletoe-based mistletoe lectins and viscotoxins. As a key player in the Indian integrative medicine space, Abnoba India bridges the gap between conventional oncology and complementary biological therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abnoba India.